Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alfasigma, Aligos, Barinthus, Bryn, DBV, Immvira, Intercept, IO, JCR, Madrigal, Neurocrine, Novaris, Ocugen, Oncolytics, Pharma Two B, Scisparc, Takeda and Xenon.